Race and delayed kidney allograft function

Nephrology Dialysis Transplantation

Volumn 13, Issue 3, 1998, Pages 704-710

  Feldman, Harold I ^a,d,e   Burns, J Eileen ^a   Roth, David A ^c   Berlin, Jesse A ^a   Szczech, Lynda ^a,f   Gayner, Robert ^b   Kushner, Steven ^a   Brayman, Kenneth L ^a   Grossman, Robert A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ST LUKE S HOSPITAL   (United States)

^c Mental Health Management Correctional Services   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e AMERICAN HEART ASSOCIATION   (United States)

^f American Kidney Fund ^*

Author keywords

Cadaveric allograft; Delayed allograft function; Kidney transplantation; Logistic regression analysis

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN; OKT 3; PREDNISONE;

ADULT; ARTICLE; CADAVER KIDNEY; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TISSUE PRESERVATION;

EID: 0031883401     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.3.704     Document Type: Article

References (33)

1. Canafax DM, Torres A, Fryd DS et al. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation 1986; 41(2): 177-181
2. Kahan BD, Mickey R, Flechner SM et al. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients. Transplantation 1987; 43(1): 65-70
3. Rosenthal JT, Danovitch GM, Wilkinson A, Ettenger RB. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991; 51(5): 1115-1118
4. Cecka JM, Cho YW, Terasaki Pl. Analyses of the UNOS Scientific Renal Transplant Registry at three years - early events affecting transplant success. Transplantation 1992; 53(1): 59-64
5. Cacciarelli T, Sumrani N, Delaney V et al. The influence of delayed renal allograft function on long-term outcome in the cyclosporine era. Clin Nephrol 1993; 39(6): 335-339
6. Pallardo LM, Garcia J, Sanchez J, Gorriz JL, Orero E, Calabuig F. Posttransplant renal allograft dysfunction as a prognostic factor in triple therapy-treated patients. Transplant Proc 1992; 24(1): 113-114
7. Halloran PF, Aprile MA, Farewell V et al. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988; 46(2): 223-228
8. Sanfilippo F, Vaughn WK, Specs EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984; 38(6): 643-648
9. Corman J, Moukarzel M, Guttmann R et al. Quebec Metro-Transplantation Multicenter Study on delayed graft function in kidney transplantation. Transplant Proc 1988; 20(1) [Suppl. 1]: 428-431
10. Franco A, Gas JM, Gasso M, Prados MC, Jimenez L, Olivares J. Prevention measures for severe acute tubular necrosis in cadaveric kidney transplants. Transplant Proc 1992; 24(1): 48-49
11. Isa WA, Robles JE, Rosell D et al. Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine. Transplant Proc 1992; 24(1): 115-117
12. Feldman H, Gayner R, Berlin J et al. Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 1996; 11 1306-1313
13. Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation 1994; 57(7): 1064-1068
14. Kerman RH, Kimball PM, Lindholm A et al. Immune risk factors: impact on the incidence and diagnosis of rejection. Transplant Proc 1993; 25(4) [Suppl. 3]: 23-25
15. Barger BO, Hudson SL, Shroyer TW et al. Influence of race on renal allograft survival in the pre- and post-cyclosporine era. Clin Transplant 1987; 217-233
16. Takemoto S, Terasaki PI. A comparison of kidney transplant survival in white and black recipients. Transplant Proc 1989; 21(6): 3865-3868
17. Kerman RH, Kimball PM, Van Buren CT et al. Influence of race on crossmatch outcome and recipient eligibility for transplantation. Transplantation 1992; 53(1): 64-67
18. Opelz G, Pfarr E, Engelmann A, Keppel E. Kidney graft survival rates in black cyclosporine-treated recipients. Collaborative Transplant Study. Transplant Proc 1989; 21(6): 3918-3920
19. Koyama H, Cecka JM. Race effects. Clin Transplant 1991; 269-280
20. Cacciarelli TV, Sumrani N, DiBenedetto A, Hong JH, Sommer BG. Influence of race on delayed renal allograft function and outcome in the cyclosporine era. Transplant Proc 1993; 25(4): 2460-2461
21. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 1991; 51(2): 338-342
22. Hosmer D, Lemeshow S. Applied Logistic Regression. Wiley, New York, 1989; 40-47
23. Kleinbaum D, Kapper L, Muller K. Applied Regression Analysis and Other Multivariate Methods. PWS-Kent Publishing, Boston, MA, 1988; 242
24. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988; 20(3) [Suppl. 3]: 63-69
25. Kalil RS, Heim-Duthoy KL, Kasiske BL. Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992; 20(1): 63-69
26. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in organ transplant recipients. Transplant Proc 1989; 21(1) (Pt 1): 833-834
27. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in renal transplant recipients: evaluation by socioeconomic groups. Transplant Proc 1989; 21(6): 3979-3981
28. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990; 49(2): 374-377
29. Lindholm A, Welsh M, Alton C, Kahan BD. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability. Clin Pharmacol Ther 1992; 52(4): 359-371
30. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54(2): 205-218
31. Moul JW, Douglas TH, McCarthy WF, McLeod DG. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 1996; 155: 1667-1673
32. Salive ME, Jones CA, Guralnik JM, Agodoa LY, Pahor M, Wallace RB. Serum creatinine levels in older adults: relationship with health status and medications. Age Ageing 1995; 24 142-150
33. Ebell MH, Smith M, Kruse JA, Drader-Wilcox J, Novak J. Effect of race on survival following in-hospital cardiopulmonary resuscitation. J Fam Pract 1995; 40: 571-577